AXIM Biotechnologies, Inc. (AXIM)

AXIM Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.16	0.05	0.45	0.46	0.51
Short-Term Investments	0	0	0	0	0.24
Cash & Cash Equivalents	0.16	0.05	0.45	0.46	0.75
Cash Growth	230.90%	-89.56%	-0.92%	-39.27%	-61.50%
Receivables	0	0	0	0	0.32
Inventory	0	0	0	0	0.49
Other Current Assets	0	0.06	0.18	0.26	0.08
Total Current Assets	0.16	0.1	0.64	0.71	1.64
Property, Plant & Equipment	0.36	0.11	0.19	0.23	0
Long-Term Investments	0.02	0.05	0.1	0.1	0
Goodwill	0	0	0	2.46	0
Intangible Assets	3.59	3.99	4.38	7.8	0.05
Other Long-Term Assets	0.01	-0.04	0.01	0.01	0
Total Long-Term Assets	3.99	4.11	4.69	10.6	0.05
Total Assets	4.15	4.21	5.32	11.31	1.69
Accounts Payable	2.78	1.32	0.91	1.07	0.77
Deferred Revenue	0.3	0.33	0	0	0
Current Debt	0.09	0.02	1.64	0.4	1.05
Other Current Liabilities	2.8	1.72	0.03	0.03	1.57
Total Current Liabilities	5.98	3.39	2.58	1.5	3.4
Long-Term Debt	5.43	5.64	5.08	5.91	5.06
Other Long-Term Liabilities	0.37	0	0	2.34	0
Total Long-Term Liabilities	5.8	5.64	5.08	8.25	5.06
Total Liabilities	11.78	9.04	7.66	9.75	8.45
Total Debt	5.66	5.66	6.72	6.31	6.1
Debt Growth	-0.11%	-15.69%	6.49%	3.38%	4.02%
Common Stock	0.02	0.02	0.01	0.01	0.01
Retained Earnings	-72.18	-64.13	-57.88	-41.85	-35.44
Comprehensive Income	-0	0.14	4.53	0.2	0.05
Shareholders' Equity	-7.63	-4.83	-2.34	1.57	-6.76
Total Liabilities and Equity	4.15	4.21	5.32	11.31	1.69
Net Cash / Debt	-5.5	-5.62	-6.27	-5.85	-5.35
Net Cash Per Share	-0.02	-0.03	-0.05	-0.05	-0.09
Working Capital	-5.82	-3.29	-1.94	-0.78	-1.76
Book Value Per Share	-0.03	-0.03	-0.02	0.01	-0.11

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.